engleski

Stability of brain damage markers NSE and S100B in cerebrospinal fluid samples

Background-aim Harmonisation of sample stability studies is required to upgrade stability databases and obtain various information. General guidelines for handling of specific analytes/proteins in cerebrospinal fluid samples still need to be specified, since stability for specific analytes is often deficiently described in manufacturer’s package inserts. For this reason we decided to run a sample stability pilot study on two biomarkers for brain damage: neuron specific enolase and S100B protein in CSF.

Neuron specific enolase ; S100B ; cerebrospinal fluid

nije evidentirano